ReviewJSES reviews, reports, and techniques2026
Biologic augmentation in rotator cuff repair: current evidence and future directions.
Review in JSES reviews, reports, and techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite surgical advancements, high failure rates of rotator cuff repairs (RCRs) remain a significant concern, with success rates varying from 16% to 94%. This paper reviews current evidence on biologic augmentation strategies, including platelet-rich plasma, mesenchymal stem cells, and biologic scaffolds, that improve healing and reduce retear rates. Current research on biologic augmentation presents mixed results. While preclinical and clinical studies show improved structural healing and functional scores, a lack of standardized protocols for application, concentration, and surgical technique leads to heterogeneity in outcomes. The review also touches on other emerging modalities like gene therapy and amniotic membrane-derived products. Biologic augmentation holds great promise for optimizing rotator cuff repairs; however, to achieve clinical effectiveness and widespread adoption, future research must focus on large-scale human trials to establish standardized protocols that would most benefit patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.